Long-term Stroke Rate Higher With CABG vs Stenting Long-term Stroke Rate Higher With CABG vs Stenting
Five-year stroke rates were lower in patients with multivessel or left main coronary artery disease who underwent stenting than in those who had coronary bypass surgery, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Five-Year Stroke Rates Lower After PCI Versus CABG
WEDNESDAY, July 18, 2018 -- Stroke rates are lower at 30 days and five years after percutaneous coronary intervention (PCI) than after coronary artery bypass grafting (CABG), according to a study published in the July 24 issue of the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 18, 2018 Category: Pharmaceuticals Source Type: news

Early Strokes Less Common in Multivessel, LM Disease With Stents
(MedPage Today) -- 30-day advantage over CABG was mainly driven by diabetes subgroup (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 16, 2018 Category: Cardiology Source Type: news

Left Main CAD: Treatment Choice Still a Toss-Up
(MedPage Today) -- EXCEL substudies fail to find much difference between PCI and CABG (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 4, 2018 Category: Cardiology Source Type: news

Over-allotment takes Hancock Jaffe IPO to nearly $9m
The underwriter of an initial public offering by Hancock Jaffe Laboratories (NSDQ:HJLI) this week exercised in full its over-allotment option, taking the gross proceeds from the flotation to nearly $9 million. The IPO, which priced on the last day of May, initially brought in $7.5 million for Irvine, Calif.-based Hancock Jaffe, which makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass grafts. The shares trade on the NASDAQ exchange under the symbol “HJLI.” Network 1 Financial Securities, the offering’s managi...
Source: Mass Device - June 15, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Vascular Wall Street Beat hancockjaffelabs Source Type: news

Radial-Artery Grafts Better Than Saphenous-Vein Grafts in CABG
WEDNESDAY, June 6, 2018 -- Compared to saphenous-vein grafts, radial-artery grafts are associated with a lower rate of adverse cardiac events at five-year follow-up in coronary-artery bypass grafting (CABG) patients, according to research published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2018 Category: Pharmaceuticals Source Type: news

Study shows taking aspirin before or after coronary
(ESA (European Society of Anaesthesiology)) New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that in patients undergoing a coronary artery bypass graft (CABG) surgery, taking aspirin before and after surgery is associated with an 18 percent to 34 percent reduced mortality risk after four years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2018 Category: International Medicine & Public Health Source Type: news

Hancock Jaffe prices $8m IPO below the range
Medical device developer Hancock Jaffe Laboratories yesterday priced its initial public offering below the re-set range it issued last week, raising nearly $8 million. Irvine, Calif.-based Hancock Jaffe makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass graft. Last December the company said it planned to float nearly 1.9 million shares at $6 to $8 apiece, for gross proceeds of $11.3 million to $15.0 million, or $13.1 million at the midpoint. But last week Hancock Jaffe cut the amount of shares to roughly 1.1 million...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Wall Street Beat hancockjaffelabs Source Type: news

FFR for CABG; Homeless CVD Care; Alcohol Effect Divergence
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 1, 2018 Category: Urology & Nephrology Source Type: news

FFR Guidance May Improve CABG Outcomes
(MedPage Today) -- Signal for fractional flow reserve advantage seen in single-center study (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 31, 2018 Category: Surgery Source Type: news

CTA Gives Percutaneous Angiography a Run for Its Money CTA Gives Percutaneous Angiography a Run for Its Money
Coronary CT angiography was on a par with conventional percutaneous angiography for answering the question of'CABG or PCI? 'Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 24, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Hancock Jaffe re-sets the range for $8m IPO
Medical device developer Hancock Jaffe Laboratories yesterday re-set the range on a pending initial public offering, which would fetch roughly $8 million at the midpoint. Irvine, Calif.-based Hancock Jaffe makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass graft. Last December the company said it planned to float nearly 1.9 million shares at $6 to $8 apiece, for gross proceeds of $11.3 million to $15.0 million, or $13.1 million at the midpoint. In a new filing yesterday, Hancock Jaffe cut the amount of shares to roughly 1.1 m...
Source: Mass Device - May 23, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Vascular Wall Street Beat hancockjaffelabs Source Type: news

One Botulinum Round Pacifies Postop AF for 3 Years: Pilot Study One Botulinum Round Pacifies Postop AF for 3 Years: Pilot Study
' We don't know why it works, but it's a fascinating new approach,'a discussant said. Botulinum injections into epicardial fat pads at CABG dramatically cut atrial fibrillation burden for up to years later.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

7 medtech stories we missed this week: May 11, 2018
[Image from unsplash.com]From ReShape submitting an approval application to Health Canada to Conavi receiving FDA clearance, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. ReShape submits for Health Canada approval of ReShape balloon ReShape announced in a May 10 press release that it has submitted an application to the Medical Devices Bureau of the Therapeutic Products Directorate in Canada to amend its existing Canadian medical device license to include distribution of the ReShape Balloon and its accessories. The ReShape Balloon is FDA approved and is a non-s...
Source: Mass Device - May 11, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Food & Drug Administration (FDA) Hospital Care Imaging mHealth (Mobile Health) Neurological Patient Monitoring Regulatory/Compliance Brainsway Conavi Exact Imaging innovativehealth MedTech PeraHealth qtm Source Type: news

Smoking and Death; Vessels for CABG: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include the best blood vessel for cardiac bypass grafts, rates of autism, five healthy lifestyle factors and their impact on mortality, and managing COPD (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - May 5, 2018 Category: Respiratory Medicine Source Type: news

Radial Artery Outlasts SVG for CABG, Cuts 5-Year Clinical Risk Radial Artery Outlasts SVG for CABG, Cuts 5-Year Clinical Risk
MIs were down at 5 years, and so were repeat revascularizations, after a radial artery graft, vs a vein graft, was added to standard internal thoracic artery bypass -- especially in specific types of patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 3, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Radial Artery Use in CABG Improves Outcomes
(MedPage Today) -- Multi-trial analysis shows reduction of major cardiac events (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 30, 2018 Category: Cardiology Source Type: news

Improved Outcomes With Public Reporting of CABG Data
MONDAY, April 30, 2018 -- Mandatory reporting of cardiac surgery outcomes for coronary artery bypass grafting (CABG) in Massachusetts from 2002 to 2014 was associated with improved outcomes, according to a study presented at the annual meeting of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2018 Category: Pharmaceuticals Source Type: news

Drug Combo Boosts 1-Year CABG Vein Graft Patency (CME/CE)
(MedPage Today) -- Ticagrelor and aspirin together better than aspirin alone (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 24, 2018 Category: Cardiology Source Type: news

Ticagrelor & #43; Aspirin Beneficial After Elective CABG
TUESDAY, April 24, 2018 -- For patients undergoing elective coronary artery bypass grafting (CABG), ticagrelor + aspirin is associated with significantly increased saphenous vein graft patency rates compared with aspirin alone, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2018 Category: Pharmaceuticals Source Type: news

Hybrid Revasc versus CABG Alone: It's a Toss-Up
(MedPage Today) -- Trial shows no difference in strokes, other events at 5 years (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 18, 2018 Category: American Health Source Type: news

Post-CABG AF: Not So Benign
Post-procedure AF, once thought to be an artifact of healing, turns out to be a sign of significant risk, a new study finds. (Source: ConsultantLive)
Source: ConsultantLive - April 10, 2018 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news

CABG Improves Survival, Stroke vs PCI in Low-LVEF Diabetes CABG Improves Survival, Stroke vs PCI in Low-LVEF Diabetes
CABG ruled for CV events, stroke, and survival in a propensity-matched observational study. Randomized trial data are thin for patients with both diabetes and poor left ventricular function.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Lower Thromboembolic Risk With New A-Fib After CABG Versus NVAF
THURSDAY, March 29, 2018 -- For patients post coronary artery bypass graft (CABG) surgery, new-onset postoperative atrial fibrillation (POAF) is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2018 Category: Pharmaceuticals Source Type: news

Post-CABG Afib Associated with Minimal Stroke Risk (CME/CE)
(MedPage Today) -- Observed risk on par with surgical patients who remain in sinus rhythm (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 28, 2018 Category: Cardiology Source Type: news

Mar 9, 2018 This Week in Cardiology Mar 9, 2018 This Week in Cardiology
Obesity in young people, type-2 diabetes, the risks of varicose veins, on-pump vs off-pump coronary artery bypass surgery and an ACC preview are the topics discussed in this week's podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

CABG Best for Diabetics with Multivessel CAD, Low LVEF
(MedPage Today) -- Long-term survival reduced with PCI (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 19, 2018 Category: Cardiology Source Type: news

Left Main Strategy Superiority May Hang On Afib Incidence
(MedPage Today) -- New onset upsets EXCEL's finding of similar outcomes for CABG, PCI (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 12, 2018 Category: Cardiology Source Type: news

Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias
Sleep-disordered breathing (SDB) is associated with abnormal cardiac repolarization before coronary artery bypass graft surgery (CABG), according to new research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Lower-Quality Medical Tx Might Have Skewed Key PCI vs CABG Trials (CME/CE)
(MedPage Today) -- Meta-analysis ties guideline adherence in surgical arm to the trial outcome (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 5, 2018 Category: American Health Source Type: news

Study: CABG Bests PCI for Younger People in the Long Run
(MedPage Today) -- Fewer repeat revascularizations, MIs over 12 years in single-center study (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 31, 2018 Category: Cardiology Source Type: news

' Mixed' Outcomes, Costs for VA's Outsourced PCI and CABG'Mixed' Outcomes, Costs for VA's Outsourced PCI and CABG
How to rate VA-purchased community care for PCI or CABG? Current metrics don't measure up, researchers conclude. Of note, one kind of center showed a mortality increase, another beat the rest on cost.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 10, 2018 Category: Cardiology Tags: Cardiology News Source Type: news

Multivessel PCI on Its 40th Anniversary: A Match for CABG? Multivessel PCI on Its 40th Anniversary: A Match for CABG?
Has contemporary PCI narrowed the gap sufficiently to declare it the preferred revascularization method for most patients with complex multi-vessel disease?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

When VA Outsources PCI, Some Patients Lose (CME/CE)
(MedPage Today) -- Survival disadvantage seen with angioplasties at non-VA centers -- but not with CABG (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - January 3, 2018 Category: Surgery Source Type: news

An Interdisciplinary Literature Review of Prehospital Use of Tranexamic Acid (TXA) in Major Bleeding
An interdisciplinary literature review Discovered in the 1950s, tranexamic acid (TXA) is an antifibrinolytic medication that, over the last decade, has drawn considerable attention from researchers, clinicians and mainstream media.1 TXA is a synthetic chemical that’s a competitive antagonist to the lysine binding site of plasminogen.2 When a fibrin clot forms in the body in response to bleeding, it’s naturally degraded over time. In major trauma and hemorrhage, it’s thought that the body’s fibrin degradation process is accelerated due to high levels of fibrinolytic factors in circulation.3 This cont...
Source: JEMS Patient Care - January 2, 2018 Category: Emergency Medicine Authors: Michael J. Carr, MD Tags: Trauma Patient Care Source Type: news

Registry Puts CABG Over PCI for Multivessel Disease in Diabetes Registry Puts CABG Over PCI for Multivessel Disease in Diabetes
The benefit, observed early on when bypass surgery has traditionally been seen as high-risk, fuels the long-running debate over the optimal up-front revascularization strategy in patients with diabetes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

CABG May Be Best Method to Revascularize in Diabetes
Cardiac, cerebrovascular events lower in patients with multivessel coronary artery disease (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 12, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Internal Medicine, Emergency Medicine, Pulmonology, Surgery, Geriatrics, Journal, Source Type: news

Current Practice of Surgical Coronary Revascularization Current Practice of Surgical Coronary Revascularization
Review the latest operative techniques and technical advances in coronary artery bypass grafting.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Percutaneous coronary intervention is a well-justified option also in severe coronary artery disease
(University of Eastern Finland) The treatment of left main coronary artery disease by percutaneous coronary intervention is associated with a smaller risk of severe cardiovascular events than coronary artery bypass grafting in the weeks following surgery. A meta-analysis of several trials and nearly 5,000 patients revealed no differences in mortality between the two treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2017 Category: International Medicine & Public Health Source Type: news

Hancock Jaffe Labs files for $13m IPO
Medical device developer Hancock Jaffe Laboratories this week set the range on a pending initial public offering, which would fetch roughly $13 million at the midpoint. Irvine, Calif.-based Hancock Jaffe makes bioprosthetic implants designed to treat chronic deep vein insufficiency, heart valve conditions and coronary artery bypass graft. The company said it plans to float nearly 1.9 million shares at $6 to $8 apiece, for gross proceeds of $11.3 million to $15.0 million, or $13.1 million at the midpoint, according to a Dec. 5 regulatory filing. Shares would trade on the NASDAQ exchange under the symbol “HJL...
Source: Mass Device - December 8, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat hancockjaffelabs Source Type: news

Medicare finalizes cuts to value-based healthcare programs
The Centers for Medicare & Medicaid Services yesterday finalized cuts to a trio of bundled payment pilot programs aimed at lowering healthcare costs and improving outcomes. The federal health insurer cut the Comprehensive Care for Joint Replacement Model, or CJR, effectively in half, from 67 geographic areas participating to 34, meaning about 470 hospital participants instead of 800. That cuts the expected savings from the CJR program from $295 million to $189 million, according to CMS. The agency also finalized the cancellation of its Episode Payment Model and the Cardiac Rehabilitation Incentive P...
Source: Mass Device - December 1, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Wall Street Beat Centers for Medicare and Medicaid Services (CMS) Reimbursement valuebasedhealthcare Source Type: news

DACAB: Ticagrelor Plus Aspirin Improves CABG Graft Patency DACAB: Ticagrelor Plus Aspirin Improves CABG Graft Patency
Results showed dual therapy with aspirin and ticagrelor resulted in improved patency of saphenous vein grafts vs either agent alone, but the data are unlikely to change practice yet, observers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

TCT: Easier Recovery with PCI vs CABG Validated in EXCEL Trial
(MedPage Today) -- But early quality of life advantage largely dissipates by 1 year (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - October 31, 2017 Category: Surgery Source Type: news

' Hybrid' Procedure on Par With CABG, PCI in Pilot Study'Hybrid' Procedure on Par With CABG, PCI in Pilot Study
The HREVS study compared minimally invasive bypass surgery plus PCI with standard CABG and PCI alone in patients with LAD disease; observers see the similar outcomes as a foundation for future studies.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

EXCEL: PCI, CABG Offer Similar Quality of Life at 3 Years EXCEL: PCI, CABG Offer Similar Quality of Life at 3 Years
Less invasive PCI offered early benefits, as expected, and bypass surgery was unable to surpass PCI in patient-reported left main coronary artery outcomes over 3 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Afternoon open heart surgery 'leads to fewer complications'
Conclusion This study found evidence of an effect that's worth investigating further to see if there are real differences in heart muscle function and risk of complications from heart surgery at different times of the day. However, there were some limitations: It took place at a single hospital, with a relatively small number of people undergoing operations. The laboratory study found differences in gene activity that suggested the body clock may play a role in making the heart better able to tolerate loss of oxygen and subsequent re-oxygenation. However, there may be other explanations for these differences. For example, ...
Source: NHS News Feed - October 27, 2017 Category: Consumer Health News Tags: Heart/lungs Source Type: news

Study: Triple-Vessel CABG Strategy Matters in the Long Run
(MedPage Today) -- Better outcomes with additional RITA or RA grafting (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - October 11, 2017 Category: Surgery Source Type: news

What Matters in Medtech Now?
With a new administration comes a new direction. That begs the question—with changes at federal agencies and proposed tax reform, is the medtech industry seeing a shift in priorities? Any Adjustments for Value-Based Care? After years of championing value-based care, CMS now plans to pull back on its bundled payment experiments. It issued a proposed rule in August that would allow many hospitals to take part voluntarily in its Comprehensive Care for Joint Replacement (CJR) program, instead of being required to participate. That program was initially the first of its kind in making participation in the bundled payment ...
Source: MDDI - October 11, 2017 Category: Medical Devices Authors: Marie Thibault Tags: Medical Device Business Source Type: news

Gender Bias May Still Limit CABG Options in Women Gender Bias May Still Limit CABG Options in Women
A new study undercuts some preconceived notions regarding use of arterial grafts in women undergoing CABG, but some argue that outcomes data are still needed to change practice.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 5, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news